A detailed history of Cresset Asset Management, LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 2,348 shares of MEDP stock, worth $729,359. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,348
Previous 2,367 0.8%
Holding current value
$729,359
Previous $974,000 19.61%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$320.58 - $457.29 $6,091 - $8,688
-19 Reduced 0.8%
2,348 $783,000
Q2 2024

Aug 14, 2024

BUY
$372.0 - $424.34 $149,172 - $170,160
401 Added 20.4%
2,367 $974,000
Q1 2024

May 15, 2024

BUY
$284.87 - $413.31 $193,996 - $281,464
681 Added 53.0%
1,966 $794,000
Q4 2023

Feb 14, 2024

SELL
$227.52 - $312.68 $55,969 - $76,919
-246 Reduced 16.07%
1,285 $393,000
Q3 2023

Nov 14, 2023

BUY
$233.98 - $281.67 $358,223 - $431,236
1,531 New
1,531 $370,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.66B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.